Active Efflux of Norfloxacin byBacteroides fragilis
暂无分享,去创建一个
[1] N. Baranova,et al. Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae , 1997, Antimicrobial agents and chemotherapy.
[2] H. Nikaido,et al. Active efflux of antimicrobial agents in wild-type strains of enterococci , 1997, Antimicrobial agents and chemotherapy.
[3] D. Hecht,et al. In vitro susceptibility of anaerobes to quinolones in the United States. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] I. Paulsen,et al. Proton-dependent multidrug efflux systems , 1996, Microbiological reviews.
[5] H. Nikaido. Multidrug efflux pumps of gram-negative bacteria , 1996, Journal of bacteriology.
[6] G. Jacoby,et al. A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.
[7] A. Driessen,et al. Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis , 1994, Journal of bacteriology.
[8] D. Livermore,et al. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin , 1994, Antimicrobial Agents and Chemotherapy.
[9] M. Midgley. Characteristics of an ethidium efflux system in Enterococcus hirae. , 1994, FEMS microbiology letters.
[10] K. Lewis,et al. Multidrug resistance pumps in bacteria: variations on a theme. , 1994, Trends in biochemical sciences.
[11] H. Nikaido,et al. Porins and specific diffusion channels in bacterial outer membranes. , 1994, The Journal of biological chemistry.
[12] H. Nikaido,et al. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples , 1993, Antimicrobial Agents and Chemotherapy.
[13] R. Nichols,et al. Wound and intraabdominal infections: microbiological considerations and approaches to treatment. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] S. Schuldiner,et al. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. , 1993, The Journal of biological chemistry.
[15] H. Nikaido,et al. Outer membranes of Gram‐negative bacteria are permeable to steroid probes , 1992, Molecular microbiology.
[16] J. Felton,et al. Transposition of Tn4351 inPorphyromonas gingivalis , 1992 .
[17] A. Neyfakh,et al. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein , 1992, Antimicrobial Agents and Chemotherapy.
[18] V. Bidnenko,et al. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[19] K. Ubukata,et al. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones , 1990, Journal of bacteriology.
[20] S. Mitsuhashi,et al. Outer membrane permeation of Bacteroides fragilis by cephalosporins , 1988, Antimicrobial Agents and Chemotherapy.
[21] S. Levy,et al. Two complementation groups mediate tetracycline resistance determined by Tn10 , 1982, Journal of bacteriology.
[22] K. Bush,et al. Antimicrobial resistance in anaerobes. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] J. Felton,et al. Transposition of Tn4351 in Porphyromonas gingivalis. , 1992, Plasmid.